Cytokine therapy

被引:33
作者
Cutler, A [1 ]
Brombacher, F [1 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
来源
NATURAL PRODUCTS AND MOLECULAR THERAPY | 2005年 / 1056卷
基金
英国惠康基金;
关键词
interleukin; monoclonal antibody; autovaccination; inflammation;
D O I
10.1196/annals.1352.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokines are a unique class of intercellular regulatory proteins that play a crucial role in initiating, maintaining, and regulating immunologic homeostatic and inflammatory processes. Indeed, measurement of cytokine profiles in patients provides a useful indication of disease status. Due to their multiple functions, including regulatory and effector cellular function in many diseases, these molecules, their receptors, and their signal transduction pathways are promising candidates for therapeutic interference. The therapeutic administration of cytokines, modulation of cytokine action, or at times gene therapy is being used for a wide range of infectious and autoimmune diseases, in immunocompromised patients with AIDS, and in neoplasia.
引用
收藏
页码:16 / 29
页数:14
相关论文
共 52 条
  • [1] Targeting cytokines in autoimmunity: new approaches, new promise
    Andreakos, E
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (03) : 435 - 447
  • [2] ARENDSE B, 2005, IN PRESS J IMMUNOL
  • [3] ASADULLAH K, 2004, ALLERGY, V3, P185
  • [4] FROM CLONING TO A COMMERCIAL REALIZATION - HUMAN ALPHA-INTERFERON
    BARON, E
    NARULA, S
    [J]. CRITICAL REVIEWS IN BIOTECHNOLOGY, 1990, 10 (03) : 179 - 190
  • [5] Bartik K, 2001, CHIRALITY, V13, P2, DOI 10.1002/1520-636X(2001)13:1<2::AID-CHIR2>3.0.CO
  • [6] 2-U
  • [7] Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
    Bielekova, B
    Richert, N
    Howard, T
    Blevins, G
    Markovic-Plese, S
    McCartin, J
    Würfel, J
    Ohayon, J
    Waidmann, TA
    McFarland, HF
    Martin, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) : 8705 - 8708
  • [8] The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    Bresnihan, B
    [J]. BIODRUGS, 2001, 15 (02) : 87 - 97
  • [9] ATTENUATION OF ALLERGIC AIRWAY INFLAMMATION IN IL-4 DEFICIENT MICE
    BRUSSELLE, GG
    KIPS, JC
    TAVERNIER, JH
    VANDERHEYDEN, JG
    CUVELIER, CA
    PAUWELS, RA
    BLUETHMANN, H
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (01) : 73 - 80
  • [10] Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response
    Bryan, SA
    O'Connor, BJ
    Matti, S
    Leckie, MJ
    Kanabar, V
    Khan, J
    Warrington, SJ
    Renzetti, L
    Rames, A
    Bock, JA
    Boyce, MJ
    Hansel, TT
    Holgate, ST
    Barnes, PJ
    [J]. LANCET, 2000, 356 (9248) : 2149 - 2153